Liquid chromatography coupled to mass spectrometry-based metabolomics and the concept of biomarker

Advances in Botanical Research

Volumn 67, Issue , 2013, Pages 159-218

  Boudah, Samia ^a   Paris, Alain ^b   Junot, Christophe ^a  

^a Institut National de la Recherche Agronomique   (France)

^b Me and oacutethodologies d'Analyse du Risque Alimentaire   (France)

Author keywords

Biological fluids; Biomarker; Liquid chromatography coupled to mass spectrometry; Metabolomics

Indexed keywords

EID: 84880634872     PISSN: 00652296     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-397922-3.00004-6     Document Type: Chapter

References (242)

1. Addona T.A., Shi X., Keshishian H., Mani D.R., Burgess M., Gillette M.A., et al. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nature Biotechnology 2011, 29(7):635-643.
2. Aharoni A., Ric de Vos C.H., Verhoeven H.A., Maliepaard C.A., Kruppa G., Bino R., et al. Nontargeted metabolome analysis by use of fourier transform ion cyclotron mass spectrometry. OMICS: A Journal of Integrative Biology 2002, 6(3):217-234.
3. Akiyama K., Chikayama E., Yuasa H., Shimada Y., Tohge T., Shinozaki K., et al. PRIMe: A Web site that assembles tools for metabolomics and transcriptomics. In Silico Biology 2008, 8(3-4):339-345.
4. Allwood J.W., Ellis D.I., Goodacre R. Metabolomic technologies and their application to the study of plants and plant-host interactions. Physiologia Plantarum 2008, 132(2):117-135.
5. Allwood J.W., Goodacre R. An introduction to liquid chromatography-mass spectrometry instrumentation applied in plant metabolomic analyses. Phytochemical Analysis 2010, 21(1):33-47.
6. Alonso A., Julia A., Beltran A., Vinaixa M., Diaz M., Ibanez L., et al. AStream: An R package for annotating LC/MS metabolomic data. Bioinformatics 2011, 27(9):1339-1340.
7. Alymani N.A., Smith M.D., Williams D.J., Petty R.D. Predictive biomarkers for personalised anti-cancer drug use: Discovery to clinical implementation. European Journal of Cancer 2010, 46(5):869-879.
8. Anderson N.L. The clinical plasma proteome: A survey of clinical assays for proteins in plasma and serum. Clinical Chemistry 2010, 56(2):177-185.
9. Angerer J., Ewers U., Wilhelm M. Human biomonitoring: State of the art. International Journal of Hygiene and Environmental Health 2007, 210(3-4):201-228.
10. Apffel A., Fischer S., Goldberg G., Goodley P.C., Kuhlmann F.E. Enhanced sensitivity for peptide mapping with electrospray liquid chromatography-mass spectrometry in the presence of signal suppression due to trifluoroacetic acid-containing mobile phases. Journal of Chromatography. A 1995, 712(1):177-190.
11. Armstrong J.A. Urinalysis in Western culture: A brief history. Kidney International 2007, 71(5):384-387.
12. Astle W., De Iorio M., Richardson S., Stephens D., Ebbels T. A Bayesian model of NMR spectra for the deconvolution and quantification of metabolites in complex biological mixtures. Journal of the American Statistical Association 2012, 107:1259-1271.
13. Bader M., Lehnert G., Angerer J. GC/MS determination of N-phenylvaline, a possible biomarker for benzene exposure in human hemoglobin by the "N-alkyl Edman method". International Archives of Occupational and Environmental Health 1994, 65(6):411-414.
14. Bajad S.U., Lu W.Y., Kimball E.H., Yuan J., Peterson C., Rabinowitz J.D. Separation and quantitation of water soluble cellular metabolites by hydrophilic interaction chromatography-tandem mass spectrometry. Journal of Chromatography. A 2006, 1125(1):76-88.
15. Baker M. In biomarkers we trust?. Nature Biotechnology 2005, 23(3):297-304.
16. Bando K., Kawahara R., Kunimatsu T., Sakai J., Kimura J., Funabashi H., et al. Influences of biofluid sample collection and handling procedures on GC-MS based metabolomic studies. Journal of Bioscience and Bioengineering 2010, 110(4):491-499.
17. Benjamini Y., Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of Royal Statistical Society B 1995, 57:289-300.
18. Bennett D.A., Waters M.D. Applying biomarker research. Environmental Health Perspectives 2000, 108(9):907-910.
19. Bennett B.D., Yuan J., Kimball E.H., Rabinowitz J.D. Absolute quantitation of intracellular metabolite concentrations by an isotope ratio-based approach. Nature Protocols 2008, 3(8):1299-1311.
20. Benton H.P., Wong D.M., Trauger S.A., Siuzdak G. XCMS2: Processing tandem mass spectrometry data for metabolite identification and structural characterization. Analytical Chemistry 2008, 80(16):6382-6389.
21. Berk M., Ebbels T., Montana G. A statistical framework for biomarker discovery in metabolomic time course data. Bioinformatics 2011, 27(14):1979-1985.
22. Bernard C. Leçons sur les phénomènes de la vie communs aux animaux et aux végétaux 1878, Baillière J.-B., Paris. A. Dastre (Ed.).
23. Biais B., Allwood J.W., Deborde C., Xu Y., Maucourt M., Beauvoit B., et al. 1H NMR, GC-EI-TOFMS, and data set correlation for fruit metabolomics: Application to spatial metabolite analysis in melon. Analytical Chemistry 2009, 81(8):2884-2894.
24. Biomarkers Definitions Working Group Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clinical Pharmacology and Therapeutics 2001, 69(3):89-95.
25. Blaise B.J., Navratil V., Domange C., Shintu L., Dumas M.E., Elena-Herrmann B., et al. Two-dimensional statistical recoupling for the identification of perturbed metabolic networks from NMR spectroscopy. Journal of Proteome Research 2010, 9(9):4513-4520.
26. Blaise B.J., Shintu L., Elena B., Emsley L., Dumas M.E., Toulhoat P. Statistical recoupling prior to significance testing in nuclear magnetic resonance based metabonomics. Analytical Chemistry 2009, 81(15):6242-6251.
27. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology 1959, 37(8):911-917.
28. Bollard M.E., Stanley E.G., Lindon J.C., Nicholson J.K., Holmes E. NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR in Biomedicine 2005, 18(3):143-162.
29. Bolten C.J., Kiefer P., Letisse F., Portais J.C., Wittmann C. Sampling for metabolome analysis of microorganisms. Analytical Chemistry 2007, 79(10):3843-3849.
30. Breitling R., Pitt A.R., Barrett M.P. Precision mapping of the metabolome. Trends in Biotechnology 2006, 24(12):543-548.
31. Brison D.R., Houghton F.D., Falconer D., Roberts S.A., Hawkhead J., Humpherson P.G., et al. Identification of viable embryos in IVF by non-invasive measurement of amino acid turnover. Human Reproduction 2004, 19(10):2319-2324.
32. Bruce S.J., Tavazzi I., Parisod V., Rezzi S., Kochhar S., Guy P.A. Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography/mass spectrometry. Analytical Chemistry 2009, 81(9):3285-3296.
33. Bylesjo M., Rantalainen M., Nicholson J.K., Holmes E., Trygg J. K-OPLS package: Kernel-based orthogonal projections to latent structures for prediction and interpretation in feature space. BMC Bioinformatics 2008, 9:106.
34. Canelas A.B., ten P.A., Ras C., Seifar R.M., van Dam J.C., van Gulik W.M., et al. Quantitative evaluation of intracellular metabolite extraction techniques for yeast metabolomics. Analytical Chemistry 2009, 81(17):7379-7389.
35. Cannon W.B. The wisdom of the body 1932, W.W. Norton, NY.
36. Carr S.A., Anderson L. Protein quantitation through targeted mass spectrometry: The way out of biomarker purgatory?. Clinical Chemistry 2008, 54(11):1749-1752.
37. Castrillo J.I., Hayes A., Mohammed S., Gaskell S.J., Oliver S.G. An optimized protocol for metabolome analysis in yeast using direct infusion electrospray mass spectrometry. Phytochemistry 2003, 62(6):929-937.
38. Chace D.H. Mass spectrometry in the clinical laboratory. Chemical Reviews 2001, 101(2):445-477.
39. Chace D.H., Lim T., Hansen C.R., Adam B.W., Hannon W.H. Quantification of malonylcarnitine in dried blood spots by use of MS/MS varies by stable isotope internal standard composition. Clinica Chimica Acta 2009, 402(1-2):14-18.
40. Chace D.H., Lim T., Hansen C.R., De Jesus V.R., De J., Hannon W.H. Improved MS/MS analysis of succinylacetone extracted from dried blood spots when combined with amino acids and acylcarnitine butyl esters. Clinica Chimica Acta 2009, 407(1-2):6-9.
41. Chace D.H., Singleton S., Diperna J., Aiello M., Foley T. Rapid metabolic and newborn screening of thyroxine (T4) from dried blood spots by MS/MS. Clinica Chimica Acta 2009, 403(1-2):178-183.
42. Chen J., Zhao X., Fritsche J., Yin P., Schmitt-Kopplin P., Wang W., et al. Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information. Analytical Chemistry 2008, 80(4):1280-1289.
43. Chirita R.I., West C., Zubrzycki S., Finaru A.L., Elfakir C. Investigations on the chromatographic behaviour of zwitterionic stationary phases used in hydrophilic interaction chromatography. Journal of Chromatography. A 2011, 1218(35):5939-5963.
44. Collier T.S., Hawkridge A.M., Georgianna D.R., Payne G.A., Muddiman D.C. Top-down identification and quantification of stable isotope labeled proteins from Aspergillus flavus using online nano-flow reversed-phase liquid chromatography coupled to a LTQ-FTICR mass spectrometer. Analytical Chemistry 2008, 80(13):4994-5001.
45. Cottingham K. HUSERMET researchers look to the metabolome for answers. Journal of Proteome Research 2008, 7(10):4213.
46. Creek D.J., Chokkathukalam A., Jankevics A., Burgess K.E., Breitling R., Barrett M.P. Stable isotope-assisted metabolomics for network-wide metabolic pathway elucidation. Analytical Chemistry 2012, 84(20):8442-8447.
47. Dai J., Carr P.W. Role of ion pairing in anionic additive effects on the separation of cationic drugs in reversed-phase liquid chromatography. Journal of Chromatography. A 2005, 1072(2):169-184.
48. Dai J., Mendonsa S.D., Bowser M.T., Lucy C.A., Carr P.W. Effect of anionic additive type on ion pair formation constants of basic pharmaceuticals. Journal of Chromatography. A 2005, 1069(2):225-234.
49. Dang L., White D.W., Gross S., Bennett B.D., Bittinger M.A., Driggers E.M., et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2009, 462(7274):739-744.
50. Darghouth D., Koehl B., Heilier J.F., Madalinski G., Bovee P., Bosman G., et al. Alterations of red blood cell metabolome in overhydrated hereditary stomatocytosis. Haematologica 2011, 96(12):1861-1865.
51. Darghouth D., Koehl B., Madalinski G., Heilier J.F., Bovee P., Xu Y., et al. Pathophysiology of sickle cell disease is mirrored by the red blood cell metabolome. Blood 2011, 117(6):e57-e66.
52. Daykin C.A., Foxall P.J., Connor S.C., Lindon J.C., Nicholson J.K. The comparison of plasma deproteinization methods for the detection of low-molecular-weight metabolites by (1)H nuclear magnetic resonance spectroscopy. Analytical Biochemistry 2002, 304(2):220-230.
53. Denery J.R., Nunes A.A., Dickerson T.J. Characterization of differences between blood sample matrices in untargeted metabolomics. Analytical Chemistry 2011, 83(3):1040-1047.
54. Dettmer K., Almstetter M.F., Appel I.J., Nurnberger N., Schlamberger G., Gronwald W., et al. Comparison of serum versus plasma collection in gas chromatography-mass spectrometry-based metabolomics. Electrophoresis 2010, 31(14):2365-2373.
55. Deventer K., Pozo O.J., Van E.P., Delbeke F.T. Qualitative detection of diuretics and acidic metabolites of other doping agents in human urine by high-performance liquid chromatography-tandem mass spectrometry: Comparison between liquid-liquid extraction and direct injection. Journal of Chromatography. A 2009, 1216(31):5819-5827.
56. Domange C., Canlet C., Traore A., Bielicki G., Keller C., Paris A., et al. Orthologous metabonomic qualification of a rodent model combined with magnetic resonance imaging for an integrated evaluation of the toxicity of Hypochoeris radicata. Chemical Research in Toxicology 2008, 21(11):2082-2096.
57. Duarte N.C., Becker S.A., Jamshidi N., Thiele I., Mo M.L., Vo T.D., et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(6):1777-1782.
58. Dumas M.E. Metabolome 2.0: Quantitative genetics and network biology of metabolic phenotypes. Molecular BioSystems 2012, 8(10):2494-2502.
59. Dumas M.E., Canlet C., Andre F., Vercauteren J., Paris A. Metabonomic assessment of physiological disruptions using 1H-13C HMBC-NMR spectroscopy combined with pattern recognition procedures performed on filtered variables. Analytical Chemistry 2002, 74(10):2261-2273.
60. Dumas M.E., Wilder S.P., Bihoreau M.T., Barton R.H., Fearnside J.F., Argoud K., et al. Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models. Nature Genetics 2007, 39(5):666-672.
61. Dunn W.B., Bailey N.J., Johnson H.E. Measuring the metabolome: Current analytical technologies. The Analyst 2005, 130(5):606-625.
62. Dunn W.B., Broadhurst D., Begley P., Zelena E., Francis-McIntyre S., Anderson N., et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nature Protocols 2011, 6(7):1060-1083.
63. Dwivedi P., Schultz A.J., Hill H.H. Metabolic profiling of human blood by high resolution ion mobility mass spectrometry (IM-MS). International Journal of Mass Spectrometry 2010, 298(1-3):78-90.
64. Eikel D., Vavrek M., Smith S., Bason C., Yeh S., Korfmacher W.A., et al. Liquid extraction surface analysis mass spectrometry (LESA-MS) as a novel profiling tool for drug distribution and metabolism analysis: The terfenadine example. Rapid Communications in Mass Spectrometry 2011, 25(23):3587-3596.
65. Euerby M.R., Petersson P. Chromatographic classification and comparison of commercially available reversed-phase liquid chromatographic columns using principal component analysis. Journal of Chromatography. A 2003, 994(1-2):13-36.
66. Fahy E., Sud M., Cotter D., Subramaniam S. LIPID MAPS online tools for lipid research. Nucleic Acids Research 2007, 35(Web Server issue):W606-W612.
67. Fenn J.B., Mann M., Meng C.K., Wong S.F., Whitehouse C.M. Electrospray ionization for mass spectrometry of large biomolecules. Science 1989, 246(4926):64-71.
68. Fiehn O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comparative and Functional Genomics 2001, 2(3):155-168.
69. Folch J., Ascoli I., Meath J.A., LeBaron N. Preparation of lipide extracts from brain tissue. The Journal of Biological Chemistry 1951, 191(2):833-841.
70. Fonville J.M., Bylesjo M., Coen M., Nicholson J.K., Holmes E., Lindon J.C., et al. Non-linear modeling of 1H NMR metabonomic data using kernel-based orthogonal projections to latent structures optimized by simulated annealing. Analytica Chimica Acta 2011, 705(1-2):72-80.
71. Fonville J.M., Maher A.D., Coen M., Holmes E., Lindon J.C., Nicholson J.K. Evaluation of full-resolution J-resolved 1H NMR projections of biofluids for metabonomics information retrieval and biomarker identification. Analytical Chemistry 2010, 82(5):1811-1821.
72. Fonville J.M., Richards S.E., Barton R.H., Boulange C., Ebbels T.M.D., Nicholson J.K., et al. The evolution of partial least squares models and related chemometric approaches in metabonomics and metabolic phenotyping. Journal of Chemometrics 2010, 24:636-649.
73. Fukushima A., Kusano M., Redestig H., Arita M., Saito K. Integrated omics approaches in plant systems biology. Current Opinion in Chemical Biology 2009, 13(5-6):532-538.
74. Gallien S., Duriez E., Crone C., Kellmann M., Moehring T., Domon B. Targeted proteomic quantification on quadrupole-orbitrap mass spectrometer. Molecular & Cellular Proteomics 2012, 11:1709-1723.
75. Garcia-Villalba R., Carrasco-Pancorbo A., Oliveras-Ferraros C., Vazquez-Martin A., Menendez J.A., Segura-Carretero A., et al. Characterization and quantification of phenolic compounds of extra-virgin olive oils with anticancer properties by a rapid and resolutive LC-ESI-TOF MS method. Journal of Pharmaceutical and Biomedical Analysis 2010, 51(2):416-429.
76. Giavalisco P., Kohl K., Hummel J., Seiwert B., Willmitzer L. (13)C isotope-labeled metabolomes allowing for improved compound annotation and relative quantification in liquid chromatography-mass spectrometry-based metabolomic research. Analytical Chemistry 2009, 81:6546-6551.
77. Gika H.G., Theodoridis G.A., Vrhovsek U., Mattivi F. Quantitative profiling of polar primary metabolites using hydrophilic interaction ultrahigh performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography. A 2012, 1259:121-127.
78. Gika H.G., Theodoridis G.A., Wilson I.D. Liquid chromatography and ultra-performance liquid chromatography-mass spectrometry fingerprinting of human urine: Sample stability under different handling and storage conditions for metabonomics studies. Journal of Chromatography. A 2008, 1189(1-2):314-322.
79. Gika H.G., Theodoridis G.A., Wingate J.E., Wilson I.D. Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: Application to human urine. Journal of Proteome Research 2007, 6(8):3291-3303.
80. Gilbert-Lopez B., Garcia-Reyes J.F., Fernandez-Alba A.R., Molina-Diaz A. Evaluation of two sample treatment methodologies for large-scale pesticide residue analysis in olive oil by fast liquid chromatography-electrospray mass spectrometry. Journal of Chromatography. A 2010, 1217(24):3736-3747.
81. Gillet L.C., Navarro P., Tate S., Rost H., Selevsek N., Reiter L., et al. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: A new concept for consistent and accurate proteome analysis. Molecular & Cellular Proteomics 2012, 11(6):O111.
82. Godat E., Madalinski G., Muller L., Heilier J.F., Labarre J., Junot C. Mass spectrometry-based methods for the determination of sulfur and related metabolite concentrations in cell extracts. Methods in Enzymology 2010, 473:41-76.
83. Guo K., Ji C., Li L. Stable-isotope dimethylation labeling combined with LC-ESI MS for quantification of amine-containing metabolites in biological samples. Analytical Chemistry 2007, 79(22):8631-8638.
84. Guo K., Li L. Differential (12)C-/(13)C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome. Analytical Chemistry 2009, 81:3919-3932.
85. Guo K., Li L. High-performance isotope labeling for profiling carboxylic acid-containing metabolites in biofluids by mass spectrometry. Analytical Chemistry 2010, 82:8789-8793.
86. Gustavsson S.A., Samskog J., Markides K.E., Langstrom B. Studies of signal suppression in liquid chromatography-electrospray ionization mass spectrometry using volatile ion-pairing reagents. Journal of Chromatography. A 2001, 937(1-2):41-47.
87. Haber M.H. Pisse prophecy: A brief history of urinalysis. Clinics in Laboratory Medicine 1988, 8(3):415-430.
88. Han X., Yang K., Gross R.W. Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses. Mass Spectrometry Reviews 2012, 31(1):134-178.
89. Hao J., Astle W., De I.M., Ebbels T.M. BATMAN-An R package for the automated quantification of metabolites from nuclear magnetic resonance spectra using a Bayesian model. Bioinformatics 2012, 28(15):2088-2090.
90. Haufroid V., Jakubowski M., Janasik B., Ligocka D., Buchet J.P., Bergamaschi E., et al. Interest of genotyping and phenotyping of drug-metabolizing enzymes for the interpretation of biological monitoring of exposure to styrene. Pharmacogenetics 2002, 12(9):691-702.
91. Hopfgartner G., Tonoli D., Varesio E. High-resolution mass spectrometry for integrated qualitative and quantitative analysis of pharmaceuticals in biological matrices. Analytical and Bioanalytical Chemistry 2012, 402(8):2587-2596.
92. Horai H., Arita M., Kanaya S., Nihei Y., Ikeda T., Suwa K., et al. MassBank: a public repository for sharing mass spectral data for life sciences. Journal of Mass Spectrometry 2010, 45(7):703-714.
93. Horning E.C., Horning M.G. Metabolic profiles: Gas-phase methods for analysis of metabolites. Clinical Chemistry 1971, 17(8):802-809.
94. Horning E.C., Horning M.G., Carroll D.I., Dzidic I., Stillwell R.N. Chemical ionization mass spectrometry. Advances in Biochemical Psychopharmacology 1973, 7:15-31.
95. Ibanez C., Simo C., Martin-Alvarez P.J., Kivipelto M., Winblad B., Cedazo-Minguez A., et al. Toward a predictive model of Alzheimer's disease progression using capillary electrophoresis-mass spectrometry metabolomics. Analytical Chemistry 2012, 84(20):8532-8540.
96. Idborg H., Zamani L., Edlund P.O., Schuppe-Koistinen I., Jacobsson S.P. Metabolic fingerprinting of rat urine by LC/MS Part 1. Analysis by hydrophilic interaction liquid chromatography-electrospray ionization mass spectrometry. Journal of Chromatography B 2005, 828(1-2):9-13.
97. Idborg-Bjorkman H., Edlund P.O., Kvalheim O.M., Schuppe-Koistinen I., Jacobsson S.P. Screening of biomarkers in rat urine using LC/electrospray ionization-MS and two-way data analysis. Analytical Chemistry 2003, 75(18):4784-4792.
98. Ipsen A., Want E.J., Lindon J.C., Ebbels T.M. A statistically rigorous test for the identification of parent-fragment pairs in LC-MS datasets. Analytical Chemistry 2010, 82(5):1766-1778.
99. Ito T., Odake T., Katoh H., Yamaguchi Y., Aoki M. High-throughput profiling of microbial extracts. Journal of Natural Products 2011, 74(5):983-988.
100. Jackson S.N., Wang H.Y., Woods A.S., Ugarov M., Egan T., Schultz J.A. Direct tissue analysis of phospholipids in rat brain using MALDI-TOFMS and MALDI-ion mobility-TOFMS. Journal of the American Society for Mass Spectrometry 2005, 16(2):133-138.
101. Jaffe J.D., Keshishian H., Chang B., Addona T.A., Gillette M.A., Carr S.A. Accurate inclusion mass screening: A bridge from unbiased discovery to targeted assay development for biomarker verification. Molecular & Cellular Proteomics 2008, 7(10):1952-1962.
102. Jiye A., Trygg J., Gullberg J., Johansson A.I., Jonsson P., Antti H., et al. Extraction and GC/MS analysis of the human blood plasma metabolome. Analytical Chemistry 2005, 77(24):8086-8094.
103. Jourdan F., Breitling R., Barrett M.P., Gilbert D. MetaNetter: Inference and visualization of high-resolution metabolomic networks. Bioinformatics 2008, 24(1):143-145.
104. Kaddurah-Daouk R., McEvoy J., Baillie R., Zhu H., Yao K., Nimgaonkar V.L., et al. Impaired plasmalogens in patients with schizophrenia. Psychiatry Research 2012, 198:347-352.
105. Kanehisa M., Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Research 2000, 28(1):27-30.
106. Karp P.D., Riley M., Saier M., Paulsen I.T., Paley S.M., Pellegrini-Toole A. The EcoCyc and MetaCyc databases. Nucleic Acids Research 2000, 28(1):56-59.
107. Katajamaa M., Miettinen J., Oresic M. MZmine: Toolbox for processing and visualization of mass spectrometry based molecular profile data. Bioinformatics 2006, 22(5):634-636.
108. Katajamaa M., Oresic M. Data processing for mass spectrometry-based metabolomics. Journal of Chromatography. A 2007, 1158(1-2):318-328.
109. Kehoe R.A., Thamann F., Cholak J. Lead absorption and excretion in relation to the diagnosis of lead poisoning. The Journal of Industrial Hygiene and Toxicology 1933, 15(5):320-340.
110. Kiefer P., Portais J.C., Vorholt J.A. Quantitative metabolome analysis using liquid chromatography-high-resolution mass spectrometry. Analytical Biochemistry 2008, 382(2):94-100.
111. Kim J.K., Harada K., Bamba T., Fukusaki E., Kobayashi A. Stable isotope dilution-based accurate comparative quantification of nitrogen-containing metabolites in Arabidopsis thaliana T87 cells using in vivo (15)N-isotope enrichment. Bioscience, Biotechnology, and Biochemistry 2005, 69(7):1331-1340.
112. Kirkland J.J. Development of some stationary phases for reversed-phase high-performance liquid chromatography. Journal of Chromatography. A 2004, 1060(1-2):9-21.
113. Kitteringham N.R., Jenkins R.E., Lane C.S., Elliott V.L., Park B.K. Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2009, 877(13):1229-1239.
114. Kopka J., Schauer N., Krueger S., Birkemeyer C., Usadel B., Bergmuller E., et al. GMD at CSB.DB: The Golm Metabolome Database. Bioinformatics 2005, 21(8):1635-1638.
115. Koulman A., Lane G.A., Harrison S.J., Volmer D.A. From differentiating metabolites to biomarkers. Analytical and Bioanalytical Chemistry 2009, 394(3):663-670.
116. Kuhl C., Tautenhahn R., Bottcher C., Larson T.R., Neumann S. CAMERA: An integrated strategy for compound spectra extraction and annotation of liquid chromatography/mass spectrometry data sets. Analytical Chemistry 2012, 84(1):283-289.
117. Lafaye A., Junot C., Ramounet-Le G.B., Fritsch P., Ezan E., Tabet J.C. Profiling of sulfoconjugates in urine by using precursor ion and neutral loss scans in tandem mass spectrometry. Application to the investigation of heavy metal toxicity in rats. Journal of Mass Spectrometry 2004, 39(6):655-664.
118. Lafaye A., Labarre J., Tabet J.C., Ezan E., Junot C. Liquid chromatography-mass spectrometry and 15N metabolic labeling for quantitative metabolic profiling. Analytical Chemistry 2005, 77(7):2026-2033.
119. Lange E., Tautenhahn R., Neumann S., Gropl C. Critical assessment of alignment procedures for LC-MS proteomics and metabolomics measurements. BMC Bioinformatics 2008, 9:375.
120. Lawton K.A., Berger A., Mitchell M., Milgram K.E., Evans A.M., Guo L., et al. Analysis of the adult human plasma metabolome. Pharmacogenomics 2008, 9(4):383-397.
121. Leandro C.C., Hancock P., Fussell R.J., Keely B.J. Comparison of ultra-performance liquid chromatography and high-performance liquid chromatography for the determination of priority pesticides in baby foods by tandem quadrupole mass spectrometry. Journal of Chromatography. A 2006, 1103(1):94-101.
122. Le Cao K.A., Boitard S., Besse P. Sparse PLS discriminant analysis: Biologically relevant feature selection and graphical displays for multiclass problems. BMC Bioinformatics 2011, 12:253.
123. Le Cao K.A., Martin P.G., Robert-Granie C., Besse P. Sparse canonical methods for biological data integration: Application to a cross-platform study. BMC Bioinformatics 2009, 10:34.
124. Lewis G.D., Wei R., Liu E., Yang E., Shi X., Martinovic M., et al. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. The Journal of Clinical Investigation 2008, 118(10):3503-3512.
125. Li Q., Zhang Q., Xu G., Yin P., Li N., Li J. Metabonomics study of intestinal transplantation using ultrahigh-performance liquid chromatography time-of-flight mass spectrometry. Digestion 2008, 77(2):122-130.
126. Lievre A., Bachet J.B., Le C.D., Boige V., Landi B., Emile J.F., et al. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Research 2006, 66(8):3992-3995.
127. Lommen A. MetAlign: Interface-driven, versatile metabolomics tool for hyphenated full-scan mass spectrometry data preprocessing. Analytical Chemistry 2009, 81(8):3079-3086.
128. Lu W., Bennett B.D., Rabinowitz J.D. Analytical strategies for LC-MS-based targeted metabolomics. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2008, 871(2):236-242.
129. Maher A.D., Fonville J.M., Coen M., Lindon J.C., Rae C.D., Nicholson J.K. Statistical total correlation spectroscopy scaling for enhancement of metabolic information recovery in biological NMR spectra. Analytical Chemistry 2012, 84(2):1083-1091.
130. Marchi I., Rudaz S., Veuthey J.L. Atmospheric pressure photoionization for coupling liquid-chromatography to mass spectrometry: A review. Talanta 2009, 78(1):1-18.
131. Marhuenda-Egea F.C., Martinez-Sabater E., Gonsalvez-Alvarez R., Lledo B., Ten J., Bernabeu R. A crucial step in assisted reproduction technology: Human embryo selection using metabolomic evaluation. Fertility and Sterility 2009, 94:772-774.
132. Mashego M.R., Wu L., van Dam J.C., Ras C., Vinke J.L., van Winden W.A., et al. MIRACLE: Mass isotopomer ratio analysis of U-13C-labeled extracts. A new method for accurate quantification of changes in concentrations of intracellular metabolites. Biotechnology and Bioengineering 2004, 85(6):620-628.
133. Matsuda F., Yonekura-Sakakibara K., Niida R., Kuromori T., Shinozaki K., Saito K. MS/MS spectral tag-based annotation of non-targeted profile of plant secondary metabolites. The Plant Journal 2009, 57(3):555-577.
134. McClellan J.E., Quarmby S.T., Yost R.A. Parent and neutral loss monitoring on a quadrupole ion trap mass spectrometer: Screening of acylcarnitines in complex mixtures. Analytical Chemistry 2002, 74(22):5799-5806.
135. Merlo M.E., Jankevics A., Takano E., Breitling R. Exploring the metabolic state of microorganisms using metabolomics. Bioanalysis 2011, 3(21):2443-2458.
136. Metz T.O., Zhang Q., Page J.S., Shen Y., Callister S.J., Jacobs J.M., et al. The future of liquid chromatography-mass spectrometry (LC-MS) in metabolic profiling and metabolomic studies for biomarker discovery. Biomarkers in Medicine 2007, 1(1):159-185.
137. Meyer H., Liebeke M., Lalk M. A protocol for the investigation of the intracellular Staphylococcus aureus metabolome. Analytical Biochemistry 2010, 401(2):250-259.
138. Michopoulos F., Edge A.M., Theodoridis G., Wilson I.D. Application of turbulent flow chromatography to the metabonomic analysis of human plasma: Comparison with protein precipitation. Journal of Separation Science 2010, 33(10):1472-1479.
139. Michopoulos F., Theodoridis G., Smith C.J., Wilson I.D. Metabolite profiles from dried biofluid spots for metabonomic studies using UPLC combined with oaToF-MS. Journal of Proteome Research 2010, 9(6):3328-3334.
140. Michopoulos F., Theodoridis G., Smith C.J., Wilson I.D. Metabolite profiles from dried blood spots for metabonomic studies using UPLC combined with orthogonal acceleration ToF-MS: Effects of different papers and sample storage stability. Bioanalysis 2011, 3(24):2757-2767.
141. Mikesh L.M., Bruns D.E. Stabilization of glucose in blood specimens: Mechanism of delay in fluoride inhibition of glycolysis. Clinical Chemistry 2008, 54(5):930-932.
142. Mochel F., Sedel F., Vanderver A., Engelke U.F., Barritault J., Yang B.Z., et al. Cerebellar ataxia with elevated cerebrospinal free sialic acid (CAFSA). Brain 2009, 132(Pt 3):801-809.
143. Mueller D.M., Duretz B., Espourteille F.A., Rentsch K.M. Development of a fully automated toxicological LC-MS(n) screening system in urine using online extraction with turbulent flow chromatography. Analytical and Bioanalytical Chemistry 2011, 400(1):89-100.
144. Narainsamy K., Cassier-Chauvat C., Junot C., Chauvat F. High performance analysis of the cyanobacterial metabolism via liquid chromatography coupled to a LTQ-Orbitrap mass spectrometer: Evidence that glucose reprograms the whole carbon metabolism and triggers oxidative stress. Metabolomics 2011, 9:21-32.
145. Nicholson J.K., Everett J.R., Lindon J.C. Longitudinal pharmacometabonomics for predicting patient responses to therapy: Drug metabolism, toxicity and efficacy. Expert Opinion on Drug Metabolism & Toxicology 2012, 8(2):135-139.
146. Nicholson J.K., Lindon J.C., Holmes E. 'Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29(11):1181-1189.
147. Nicholson G., Rantalainen M., Li J.V., Maher A.D., Malmodin D., Ahmadi K.R., et al. A genome-wide metabolic QTL analysis in Europeans implicates two loci shaped by recent positive selection. PLoS Genetics 2011, 7(9):e1002270.
148. Nordstrom A., O'Maille G., Qin C., Siuzdak G. Nonlinear data alignment for UPLC-MS and HPLC-MS based metabolomics: Quantitative analysis of endogenous and exogenous metabolites in human serum. Analytical Chemistry 2006, 78(10):3289-3295.
149. Oberacher H., Pavlic M., Libiseller K., Schubert B., Sulyok M., Schuhmacher R., et al. On the inter-instrument and the inter-laboratory transferability of a tandem mass spectral reference library: 2. Optimization and characterization of the search algorithm. Journal of Mass Spectrometry 2009, 44(4):494-502.
150. Oberacher H., Pavlic M., Libiseller K., Schubert B., Sulyok M., Schuhmacher R., et al. On the inter-instrument and inter-laboratory transferability of a tandem mass spectral reference library: 1. Results of an Austrian multicenter study. Journal of Mass Spectrometry 2009, 44(4):485-493.
151. Oliver S.G., Winson M.K., Kell D.B., Baganz F. Systematic functional analysis of the yeast genome. Trends in Biotechnology 1998, 16(9):373-378.
152. Oresic M., Simell S., Sysi-Aho M., Nanto-Salonen K., Seppanen-Laakso T., Parikka V., et al. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. The Journal of Experimental Medicine 2008, 205(13):2975-2984.
153. Oreskovic D., Klarica M. The formation of cerebrospinal fluid: Nearly a hundred years of interpretations and misinterpretations. Brain Research Reviews 2010, 64(2):241-262.
154. Palit M., Mallard G. Fragmentation energy index for universalization of fragmentation energy in ion trap mass spectrometers for the analysis of chemical weapon convention related chemicals by atmospheric pressure ionization-tandem mass spectrometry analysis. Analytical Chemistry 2009, 81(7):2477-2485.
155. Parvy P., Bardet J., Rabier D., Bonnefont J.P., Kamoun P. A new pitfall in plasma amino acid analysis. Clinical Chemistry 1989, 35(1):178.
156. Pasikanti K.K., Ho P.C., Chan E.C. Gas chromatography/mass spectrometry in metabolic profiling of biological fluids. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2008, 871(2):202-211.
157. Paustenbach D.J. The practice of exposure assessment: A state-of-the-art review. Journal of Toxicology and Environmental Health, Part B. Critical Reviews 2001, 3:179-291.
158. Pearce S.J., Schrenk H.H., Yant W.P. Microcolorimetric determination of benzene in blood and urine 1936, United States Bureau of Mines, 3302. Chem Abstr 30:5600.
159. Pepe M.S., Etzioni R., Feng Z., Potter J.D., Thompson M.L., Thornquist M., et al. Phases of biomarker development for early detection of cancer. Journal of the National Cancer Institute 2001, 93(14):1054-1061.
160. Pesek J.J., Matyska M.T., Fischer S.M. Improvement of peak shape in aqueous normal phase analysis of anionic metabolites. Journal of Separation Science 2011, 34(24):3509-3516.
161. Pesek J.J., Matyska M.T., Fischer S.M., Sana T.R. Analysis of hydrophilic metabolites by high-performance liquid chromatography-mass spectrometry using a silica hydride-based stationary phase. Journal of Chromatography. A 2008, 1204(1):48-55.
162. Peters S., van V.E., Janssen H.G. Parameter selection for peak alignment in chromatographic sample profiling: Objective quality indicators and use of control samples. Analytical and Bioanalytical Chemistry 2009, 394(5):1273-1281.
163. Plumb R.S., Stumpf C.L., Granger J.H., Castro-Perez J., Haselden J.N., Dear G.J. Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids. Rapid Communications in Mass Spectrometry 2003, 17(23):2632-2638.
164. Pluskal T., Castillo S., Villar-Briones A., Oresic M. MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics 2010, 11:395.
165. Psychogios N., Hau D.D., Peng J., Guo A.C., Mandal R., Bouatra S., et al. The human serum metabolome. PloS One 2011, 6:e16957.
166. Quinones M.P., Kaddurah-Daouk R. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiology of Disease 2009, 35(2):165-176.
167. Ramautar R., Mayboroda O.A., Somsen G.W., de Jong G.J. CE-MS for metabolomics: Developments and applications in the period 2008-2010. Electrophoresis 2011, 32(1):52-65.
168. Ramautar R., Somsen G.W., de Jong G.J. CE-MS in metabolomics. Electrophoresis 2009, 30(1):276-291.
169. Ramautar R., Somsen G.W., de Jong G.J. CE-MS for metabolomics: Developments and applications in the period 2010-2012. Electrophoresis 2012, 34:86-98.
170. Richards S.E., Dumas M.E., Fonville J.M., Ebbels T.M.D., Holmes E., Nicholson J.K. Intra- and inter-omic fusion of metabolic profiling data in a systems biology framework. Chemometrics and Intelligent Laboratory Systems 2011, 104:S121-S131.
171. Rifai N., Gillette M.A., Carr S.A. Protein biomarker discovery and validation: The long and uncertain path to clinical utility. Nature Biotechnology 2006, 24(8):971-983.
172. Ritchie S.A., Ahiahonu P.W., Jayasinghe D., Heath D., Liu J., Lu Y., et al. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: Implications for early screening and detection. BMC Medicine 2010, 8:13.
173. Robb D.B., Covey T.R., Bruins A.P. Atmospheric pressure photoionization: An ionization method for liquid chromatography-mass spectrometry. Analytical Chemistry 2000, 72(15):3653-3659.
174. Roberts J.K. NMR adventures in the metabolic labyrinth within plants. Trends in Plant Science 2000, 5(1):30-34.
175. Rohart F., Paris A., Laurent B., Canlet C., Molina J., Mercat M.J., et al. Phenotypic prediction based on metabolomic data on the growing pig from three main European breeds. Journal of Animal Science 2012, 90:4729-4740.
176. Roux A., Lison D., Junot C., Heilier J.F. Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review. Clinical Biochemistry 2011, 44(1):119-135.
177. Roux A., Xu Y., Heilier J.F., Olivier M.F., Ezan E., Tabet J.C., et al. Annotation of the human adult urinary metabolome and metabolite identification using ultra high performance liquid chromatography coupled to a linear quadrupole ion trap-orbitrap mass spectrometer. Analytical Chemistry 2012, 84(15):6429-6437.
178. Sabatine M.S., Liu E., Morrow D.A., Heller E., McCarroll R., Wiegand R., et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 2005, 112(25):3868-3875.
179. Savitski M.M., Sweetman G., Askenazi M., Marto J.A., Lang M., Zinn N., et al. Delayed fragmentation and optimized isolation width settings for improvement of protein identification and accuracy of isobaric mass tag quantification on Orbitrap-type mass spectrometers. Analytical Chemistry 2011, 83(23):8959-8967.
180. Shah V.P., Midha K.K., Findlay J.W., Hill H.M., Hulse J.D., McGilveray I.J., et al. Bioanalytical method validation-A revisit with a decade of progress. Pharmaceutical Research 2000, 17(12):1551-1557.
181. Shibue M., Mant C.T., Hodges R.S. The perchlorate anion is more effective than the trifluoroacetate anion as an ion-pairing reagent for reversed-phase chromatography of peptides. Journal of Chromatography. A 2005, 1080(1):49-57.
182. Shibue M., Mant C.T., Hodges R.S. Effect of anionic ion-pairing reagent concentration (1-60 mM) on reversed-phase liquid chromatography elution behaviour of peptides. Journal of Chromatography. A 2005, 1080(1):58-67.
183. Shibue M., Mant C.T., Hodges R.S. Effect of anionic ion-pairing reagent hydrophobicity on selectivity of peptide separations by reversed-phase liquid chromatography. Journal of Chromatography. A 2005, 1080(1):68-75.
184. Shimizu A., Ohe T., Chiba M. A novel method for the determination of the site of glucuronidation by ion mobility spectrometry-mass spectrometry. Drug Metabolism and Disposition 2012, 40(8):1456-1459.
185. Shortreed M.R., Lamos S.M., Frey B.L., Phillips M.F., Patel M., Belshaw P.J., et al. Ionizable isotopic labeling reagent for relative quantification of amine metabolites by mass spectrometry. Analytical Chemistry 2006, 78(18):6398-6403.
186. Simonsen K.W., Hermansson S., Steentoft A., Linnet K. A validated method for simultaneous screening and quantification of twenty-three benzodiazepines and metabolites plus zopiclone and zaleplone in whole blood by liquid-liquid extraction and ultra-performance liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology 2010, 34(6):332-341.
187. Simonsen K.W., Steentoft A., Buck M., Hansen L., Linnet K. Screening and quantitative determination of twelve acidic and neutral pharmaceuticals in whole blood by liquid-liquid extraction and liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology 2010, 34(7):367-373.
188. Sinclair A.J., Viant M.R., Ball A.K., Burdon M.A., Walker E.A., Stewart P.M., et al. NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases-A diagnostic tool?. NMR in Biomedicine 2010, 23(2):123-132.
189. Smedsgaard J., Frisvad J.C. Using direct electrospray mass spectrometry in taxonomy and secondary metabolite profiling of crude fungal extracts. Journal of Microbiological Methods 1996, 25(1):5-17.
190. Smith C.A., O'Maille G., Want E.J., Qin C., Trauger S.A., Brandon T.R., et al. METLIN: A metabolite mass spectral database. Therapeutic Drug Monitoring 2005, 27(6):747-751.
191. Smith C.A., Want E.J., O'Maille G., Abagyan R., Siuzdak G. XCMS: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Analytical Chemistry 2006, 78(3):779-787.
192. Soga T., Ueno Y., Naraoka H., Ohashi Y., Tomita M., Nishioka T. Simultaneous determination of anionic intermediates for Bacillus subtilis metabolic pathways by capillary electrophoresis electrospray ionization mass spectrometry. Analytical Chemistry 2002, 74(10):2233-2239.
193. Sreekumar A., Poisson L.M., Rajendiran T.M., Khan A.P., Cao Q., Yu J., et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009, 457(7231):910-914.
194. Steinbeck C., Conesa P., Haug K., Mahendraker T., Williams M., Maguire E., et al. MetaboLights: Towards a new COSMOS of metabolomics data management. Metabolomics 2012, 8(5):757-760.
195. Stella C., Rudaz S., Gauvrit J.Y., Lanteri P., Huteau A., Tchapla A., et al. Characterization and comparison of the chromatographic performance of different types of reversed-phase stationary phases. Journal of Pharmaceutical and Biomedical Analysis 2007, 43(1):89-98.
196. Storey J.D., Tibshirani R. Statistical significance for genomewide studies. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(16):9440-9445.
197. Strimmer K. A unified approach to false discovery rate estimation. BMC Bioinformatics 2008, 9:303.
198. Sumner L.W., Amberg A., Barrett D., Beale M.H., Beger R., Daykin C.A., et al. Proposed minimum reporting standards for chemical analysis. Metabolomics 2007, 3(3):211-221.
199. Sumner L.W., Mendes P., Dixon R.A. Plant metabolomics: Large-scale phytochemistry in the functional genomics era. Phytochemistry 2003, 62(6):817-836.
200. Sun J., Schnackenberg L.K., Holland R.D., Schmitt T.C., Cantor G.H., Dragan Y.P., et al. Metabonomics evaluation of urine from rats given acute and chronic doses of acetaminophen using NMR and UPLC/MS. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2008, 871(2):328-340.
201. Surinova S., Schiess R., Huttenhain R., Cerciello F., Wollscheid B., Aebersold R. On the development of plasma protein biomarkers. Journal of Proteome Research 2011, 10(1):5-16.
202. Sysi-Aho M., Katajamaa M., Yetukuri L., Oresic M. Normalization method for metabolomics data using optimal selection of multiple internal standards. BMC Bioinformatics 2007, 8:93.
203. Tautenhahn R., Böttcher C., Neumann S. Annotation of LC/ESI-MS mass signals 2007, 371-380. Springer-Verlag, Berlin, Heidelberg.
204. Tautenhahn R., Bottcher C., Neumann S. Highly sensitive feature detection for high resolution LC/MS. BMC Bioinformatics 2008, 9:504.
205. Tautenhahn R., Patti G.J., Kalisiak E., Miyamoto T., Schmidt M., Lo F.Y., et al. metaXCMS: Second-order analysis of untargeted metabolomics data. Analytical Chemistry 2011, 83(3):696-700.
206. Tautenhahn R., Patti G.J., Rinehart D., Siuzdak G. XCMS Online: A web-based platform to process untargeted metabolomic data. Analytical Chemistry 2012, 84(11):5035-5039.
207. Teahan O., Gamble S., Holmes E., Waxman J., Nicholson J.K., Bevan C., et al. Impact of analytical bias in metabonomic studies of human blood serum and plasma. Analytical Chemistry 2006, 78(13):4307-4318.
208. Timbrell J.A. Biomarkers in toxicology. Toxicology 1998, 129(1):1-12.
209. Tiziani S., Emwas A.H., Lodi A., Ludwig C., Bunce C.M., Viant M.R., et al. Optimized metabolite extraction from blood serum for 1H nuclear magnetic resonance spectroscopy. Analytical Biochemistry 2008, 377(1):16-23.
210. Tolstikov V.V., Fiehn O. Analysis of highly polar compounds of plant origin: Combination of hydrophilic interaction chromatography and electrospray ion trap mass spectrometry. Analytical Biochemistry 2002, 301(2):298-307.
211. Trusheim M.R., Burgess B., Hu S.X., Long T., Averbuch S.D., Flynn A.A., et al. Quantifying factors for the success of stratified medicine. Nature Reviews. Drug Discovery 2011, 10(11):817-833.
212. Trygg J., Holmes E., Lundstedt T. Chemometrics in metabonomics. Journal of Proteome Research 2007, 6(2):469-479.
213. Turer A.T., Stevens R.D., Bain J.R., Muehlbauer M.J., van der W.J., Mathew J.P., et al. Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion. Circulation 2009, 119(13):1736-1746.
214. Vander Heiden M.G., Locasale J.W., Swanson K.D., Sharfi H., Heffron G.J., Amador-Noguez D., et al. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 2010, 5998:1492-1499.
215. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415(6871):530-536.
216. Vassella F., Hellstrom B., Wengle B. Urinary excretion of tryptophan metabolites in the healthy infant. Pediatrics 1962, 30:585-591.
217. Vaughan A.A., Dunn W.B., Allwood J.W., Wedge D.C., Blackhall F.H., Whetton A.D., et al. Liquid chromatography-mass spectrometry calibration transfer and metabolomics data fusion. Analytical Chemistry 2012, 84(22):9848-9857.
218. Vervoort R.J., Ruyter E., Debets A.J., Claessens H.A., Cramers C.A., de Jong G.J. Characterisation of reversed-phase stationary phases for the liquid chromatographic analysis of basic pharmaceuticals by thermodynamic data. Journal of Chromatography. A 2002, 964(1-2):67-76.
219. Vuckovic D. Current trends and challenges in sample preparation for global metabolomics using liquid chromatography-mass spectrometry. Analytical and Bioanalytical Chemistry 2012, 403(6):1523-1548.
220. Vuckovic D., Pawliszyn J. Systematic evaluation of solid-phase microextraction coatings for untargeted metabolomic profiling of biological fluids by liquid chromatography-mass spectrometry. Analytical Chemistry 2011, 83(6):1944-1954.
221. Wang T.J., Larson M.G., Vasan R.S., Cheng S., Rhee E.P., McCabe E., et al. Metabolite profiles and the risk of developing diabetes. Nature Medicine 2011, 17(4):448-453.
222. Want E.J., O'Maille G., Smith C.A., Brandon T.R., Uritboonthai W., Qin C., et al. Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. Analytical Chemistry 2006, 78(3):743-752.
223. Want E.J., Wilson I.D., Gika H., Theodoridis G., Plumb R.S., Shockcor J., et al. Global metabolic profiling procedures for urine using UPLC-MS. Nature Protocols 2010, 5(6):1005-1018.
224. Wei R., Li G., Seymour A.B. High-throughput and multiplexed LC/MS/MRM method for targeted metabolomics. Analytical Chemistry 2010, 82(13):5527-5533.
225. Werner E., Croixmarie V., Umbdenstock T., Ezan E., Chaminade P., Tabet J.C., et al. Mass spectrometry-based metabolomics: Accelerating the characterization of discriminating signals by combining statistical correlations and ultrahigh resolution. Analytical Chemistry 2008, 80(13):4918-4932.
226. Werner E., Heilier J.F., Ducruix C., Ezan E., Junot C., Tabet J.C. Mass spectrometry for the identification of the discriminating signals from metabolomics: Current status and future trends. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2008, 871(2):143-163.
227. Whiteaker J.R., Lin C., Kennedy J., Hou L., Trute M., Sokal I., et al. A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nature Biotechnology 2011, 29(7):625-634.
228. Wiklund S., Johansson E., Sjostrom L., Mellerowicz E.J., Edlund U., Shockcor J.P., et al. Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Analytical Chemistry 2008, 80(1):115-122.
229. Williams R.E., Major H., Lock E.A., Lenz E.M., Wilson I.D. D-Serine-induced nephrotoxicity: A HPLC-TOF/MS-based metabonomics approach. Toxicology 2005, 207(2):179-190.
230. Wilson I.D., Plumb R., Granger J., Major H., Williams R., Lenz E.M. HPLC-MS-based methods for the study of metabonomics. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2005, 817(1):67-76.
231. Wishart D.S., Tzur D., Knox C., Eisner R., Guo A.C., Young N., et al. HMDB: The Human Metabolome Database. Nucleic Acids Research 2007, 35(Database issue):D521-D526.
232. Wold S., Martens H., Wold H. The multivariate calibration method in chemistry solved by the PLS method 1983, Springer-Verlag, Heidelberg. A. Ruhe, B. Kagstrom (Eds.).
233. Wold S., Ruhe A., Wold H., Dunn W.J. The Collinearity problem in linear regression. The partial least squares approach to generalized inverses. SIAM Journal on Scientific and Statistical Computing 1984, 5:735-743.
234. Wolfender J.L., Glauser G., Boccard J., Rudaz S. MS-based plant metabolomic approaches for biomarker discovery. Natural Product Communications 2009, 4(10):1417-1430.
235. Wu J.Y., Kao H.J., Li S.C., Stevens R., Hillman S., Millington D., et al. ENU mutagenesis identifies mice with mitochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease. The Journal of Clinical Investigation 2004, 113(3):434-440.
236. Wu H., Zhang J., Norem K., El-Shourbagy T.A. Simultaneous determination of a hydrophobic drug candidate and its metabolite in human plasma with salting-out assisted liquid/liquid extraction using a mass spectrometry friendly salt. Journal of Pharmaceutical and Biomedical Analysis 2008, 48(4):1243-1248.
237. Yalow R.S., Berson S.A. Immunoassay of endogenous plasma insulin in man. The Journal of Clinical Investigation 1960, 39:1157-1175.
238. Yalow R.S., Berson S.A. Plasma insulin concentrations in nondiabetic and early diabetic subjects. Determinations by a new sensitive immuno-assay technic. Diabetes 1960, 9:254-260.
239. Yoon H.R., Kim H., Cho S.H. Quantitative analysis of acyl-lysophosphatidic acid in plasma using negative ionization tandem mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2003, 788(1):85-92.
240. Yu Z., Kastenmuller G., He Y., Belcredi P., Moller G., Prehn C., et al. Differences between human plasma and serum metabolite profiles. PloS One 2011, 6(7):e21230.
241. Zhang T., Creek D.J., Barrett M.P., Blackburn G., Watson D.G. Evaluation of coupling reversed phase, aqueous normal phase, and hydrophilic interaction liquid chromatography with Orbitrap mass spectrometry for metabolomic studies of human urine. Analytical Chemistry 2012, 84(4):1994-2001.
242. Zhang Y., Dai Y., Wen J., Zhang W., Grenz A., Sun H., et al. Detrimental effects of adenosine signaling in sickle cell disease. Nature Medicine 2011, 17(1):79-86.